MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2016 International Congress

    Levodopa-carbidopa intestinal gel in routine care of advanced Parkinson’s disease patients: Final long-term non-motor, quality of life and safety results from the GLORIA registry

    K.R. Chaudhuri, Z. Pirtosek, B. Pickut, W. Poewe, F. Valldeoriola, L. Defebvre, R. Jech, P. Odin, C. Winkler, J. Szasz, K. Onuk, A. Yegin, L. Bergmann, A. Antonini (London, United Kingdom)

    Objective: To evaluate the tolerability and effect of levodopa-carbidopa intestinal gel (LCIG, designated in the US as carbidopa-levodopa enteral suspension) on non-motor symptoms (NMS), quality…
  • 2016 International Congress

    Reflex saccades changes can estimate long-term symptom progression in DBS STN and MED Parkinson’s disease patients (PD)

    S. Szlufik, A. Przybyszewski, J. Dutkiewicz, P. Habela, T. Mandat, D. Koziorowski (Warsaw, Poland)

    Objective: The aim of this study was to evaluate the impact of STN DBS on RS parameters in PD. We have compared disease progression in…
  • 2016 International Congress

    Randomized controlled trial protocol: Balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease

    T.T.C. Capato, J. Tornai, V.F. Gianguiagi, R.R. Firmino, E.R. Barbosa, M.E. Piemonte (São Paulo, Brazil)

    Objective: Is to evaluate the effects of balance training with rhythmical(BRT) which is a motor program to improve balance associated with rhythmical auditory cues (RACs).…
  • 2016 International Congress

    Risk factors for premature withdraw from the LS-1 PD study

    J.Y. Fang, S. Luo, M. Huang, R.B. Dewey, R. Hauser, G. Chen (Nashville, TN, USA)

    Objective: To identify risk factors for premature withdrawal from a large, multi-center Parkinson's disease clinical trial of possible neuroprotection. Background: Premature withdrawal (PW) of subjects…
  • 2016 International Congress

    Clinical characteristics of Parkinson’s disease and essential tremor patients undergoing deep brain stimulation surgery: Five-year data from Columbia University Medical Center (2009 – 2014)

    M. Kestenbaum, D. Robakis, B. Ford, R.N. Alcalay, E.D. Louis (Tel Aviv, Israel)

    Objective: To compare the clinical characteristics of essential tremor (ET) and Parkinson's disease (PD) patients who underwent deep brain stimulation (DBS) surgery to those of…
  • 2016 International Congress

    An investigation of Parkinson’s disease patients’ desired control over the DBS stimulator

    C.S. Kubu, J. Vitek, S.E. Cooper, A. Machado, P.J. Ford (Cleveland, OH, USA)

    Objective: To understand changes in patients' desired control of the DBS stimulator in a consecutive series of subjects who underwent DBS for the treatment of…
  • 2016 International Congress

    Weight changes in PD patients post-DBS: A look at the factors involved

    B. Ahmed, L.B. Almeida, A. Bona, S. De Jesus, D. Martinez-Ramirez, M.S. Okun (Gainesville, FL, USA)

    Objective: To evaluate the factors associated with weight changes in Parkinson's disease (PD) patients after deep brain stimulation (DBS) surgery. Background: DBS is a well-established…
  • 2016 International Congress

    Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease

    O.L. Tondiy (Kharkiv, Ukraine)

    Objective: Stage of Parkinson's disease was determined by the Hoehn&Yahr Scale. Background: The effect of the low-frequent variable magnetic field, the ultratonetherapy and balneotherapy on…
  • 2016 International Congress

    1-year clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes

    E. Shalaeva, B. Janabaev, Q. Matmurotov, U. Kasimov, U. Pulatov, A. Bobabekov, M. Bozorboev (Tashkent, Uzbekistan)

    Objective: To evaluate clinical outcomes in patients with parkinsonism syndrome with/without type 2 diabetes (T2DM) 1-year after operation due to lower extremity artery disease (LEAD)…
  • 2016 International Congress

    Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease

    P. Chana-Cuevas, C. Juri, V. Kramer, R. Pruzzo, P. Riss, A. Amaral, F. Rösch, H. Amaral (Santiago, Chile)

    Objective: To evaluate the differences in striatal subregional dopamine transporter loss in Parkinson's disease (PD) and supranuclear palsy (PSP) and the diagnostic value of [18F]PR04.MZ…
  • « Previous Page
  • 1
  • …
  • 345
  • 346
  • 347
  • 348
  • 349
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Advanced Search
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley